InvestorsObserver
×
News Home

Neuronetics Inc (STIM) is higher by 23.22% in a Week, Should You Buy?

Monday, March 25, 2024 09:33 AM | InvestorsObserver Analysts

Mentioned in this article

Neuronetics Inc (STIM) is higher by 23.22% in a Week, Should You Buy?

Neuronetics Inc (STIM) is near the top in its industry group according to InvestorsObserver. STIM gets an overall rating of 81. That means it scores higher than 81 percent of stocks. Neuronetics Inc gets a 100 rank in the Diagnostics & Research industry. Diagnostics & Research is number 78 out of 148 industries.

Overall Score - 81
STIM has an Overall Score of 81. Find out what this means to you and get the rest of the rankings on STIM!

What do These Ratings Mean?

Searching for the best stocks to invest in can be difficult. There are thousands of options and it can be confusing on what actually constitutes a great value. InvestorsObserver allows you to choose from eight unique metrics to view the top industries and the best performing stocks in that industry. A score of 81 would rank higher than 81 percent of all stocks.
Our proprietary scoring system captures technical factors, fundamental analysis and the opinions of analysts on Wall Street. This makes InvestorsObserver’s overall rating a great way to get started, regardless of your investing style. Percentile-ranked scores are also easy to understand. A score of 100 is the top and a 0 is the bottom. There’s no need to try to remember what is “good” for a bunch of complicated ratios, just pay attention to which numbers are the highest.

What's Happening With Neuronetics Inc Stock Today?

Neuronetics Inc (STIM) stock has risen 10.4% while the S&P 500 is down -0.22% as of 9:33 AM on Monday, Mar 25. STIM is up $0.44 from the previous closing price of $4.23 on volume of 264,516 shares. Over the past year the S&P 500 has risen 31.31% while STIM is up 59.39%. STIM lost -$1.05 per share the over the last 12 months. Click Here to get the full Stock Report for Neuronetics Inc stock.

You May Also Like

Get the InvestorsObserver App

InvestorsObserver App
iOS App Android App